Shire product director Mike Boken uses the example of ADHD drug Vyvanse to illustrate the potential pharmaceutical marketing advantages of using patient debit, copay and voucher offers versus giving physicians traditional product samples
Measuring online consumer healthcare conversations can help provide pharma companies with insights for message planning, competitive intelligence and new product development. Ira Haimowitz and Claudia Obata report
Alex Gorsky, worldwide chairman for Johnson & Johnson’s surgical care group and this year’s Healthcare Businesswomen’s Association Honorable Mentor, says mentoring is a two-way street.
Several prominent universities have banned gifts from pharma companies, including everything from paid lunches to drug samples, and the trend seems likely to continue.
Remember what happened with websites in the 1990s? It seemed as if corporate marketing went from “Exactly how do they work?” to “Wow, we gotta have one,” overnight.
The need for increased health and science literacy has never been greater. It’s a crucial gap that must be filled if we are to promote evidence-based decision making, increase productivity, enhance economic competitiveness and ensure the continuation of the democratic process.
Will traditional media get a boost?
April 15, 2009
7:30 pm
The AMA is the latest association to call for an increasingly limited financial relationship with pharma. With less opportunity for sponsorships, will journal advertising and other professional media see a much-needed lift?
Vantage Point: Healthcare system needs to change
April 15, 2009
8:38 pm
Waste not, want not. This phrase is typically credited to Ben Franklin, but its profoundness was evident throughout the PMRG meeting in Las Vegas in March.
IMS, SDI want Supremes to look at prescription data laws